Global Non-small Cell Lung Cancer Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	177 Pages	TechNavio	July, 2024	INF19033514

Best Price Guarantee
Price	from $2,500
Length	177 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033514

Global Non-Small Cell Lung Cancer Drugs Market 2024-2028

The non-small cell lung cancer drugs market is forecasted to grow by USD 21061.2 mn during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the non-small cell lung cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of nsclc, strong drug pipeline and recent drug approvals, and availability of patient assistance programs.

Technavio's non-small cell lung cancer drugs market is segmented as below:

By Type

Adenocarcinoma
Squamous cell carcinoma
Large cell carcinoma

By Product

Biologics
Small molecule targeted therapy
Chemotherapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the introduction and approval of combination therapies as one of the prime reasons driving the non-small cell lung cancer drugs market growth during the next few years. Also, increase in strategic alliances to develop nsclc drugs and use of predictive biomarkers for development of cost-effective therapies will lead to sizable demand in the market.

The report on the non-small cell lung cancer drugs market covers the following areas:

Non-small cell lung cancer drugs market sizing
Non-small cell lung cancer drugs market forecast
Non-small cell lung cancer drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-small cell lung cancer drugs market vendors that include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, BeiGene Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., DeuterOncology NV, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Innovent Biologics Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Merck KGaA, Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc., PharmaMar SA, Regeneron Pharmaceuticals Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.. Also, the non-small cell lung cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Non-Small Cell Lung Cancer Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Non-Small Cell Lung Cancer Drugs Market 2018 - 2022 ($ million); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 Adenocarcinoma - Market size and forecast 2023-2028; Chart on Adenocarcinoma - Market size and forecast 2023-2028 ($ million); Data Table on Adenocarcinoma - Market size and forecast 2023-2028 ($ million); Chart on Adenocarcinoma - Year-over-year growth 2023-2028 (%); Data Table on Adenocarcinoma - Year-over-year growth 2023-2028 (%); 6.4 Squamous cell carcinoma - Market size and forecast 2023-2028; Chart on Squamous cell carcinoma - Market size and forecast 2023-2028 ($ million); Data Table on Squamous cell carcinoma - Market size and forecast 2023-2028 ($ million); Chart on Squamous cell carcinoma - Year-over-year growth 2023-2028 (%); Data Table on Squamous cell carcinoma - Year-over-year growth 2023-2028 (%); 6.5 Large cell carcinoma - Market size and forecast 2023-2028; Chart on Large cell carcinoma - Market size and forecast 2023-2028 ($ million); Data Table on Large cell carcinoma - Market size and forecast 2023-2028 ($ million); Chart on Large cell carcinoma - Year-over-year growth 2023-2028 (%); Data Table on Large cell carcinoma - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 7.3 Biologics - Market size and forecast 2023-2028; Chart on Biologics - Market size and forecast 2023-2028 ($ million); Data Table on Biologics - Market size and forecast 2023-2028 ($ million); Chart on Biologics - Year-over-year growth 2023-2028 (%); Data Table on Biologics - Year-over-year growth 2023-2028 (%); 7.4 Small molecule targeted therapy - Market size and forecast 2023-2028; Chart on Small molecule targeted therapy - Market size and forecast 2023-2028 ($ million); Data Table on Small molecule targeted therapy - Market size and forecast 2023-2028 ($ million); Chart on Small molecule targeted therapy - Year-over-year growth 2023-2028 (%); Data Table on Small molecule targeted therapy - Year-over-year growth 2023-2028 (%); 7.5 Chemotherapy - Market size and forecast 2023-2028; Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million); Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million); Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.5 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key news; Astellas Pharma Inc. - Key offerings; 12.6 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.7 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.8 BeiGene Ltd.; BeiGene Ltd. - Overview; BeiGene Ltd. - Business segments; BeiGene Ltd. - Key offerings; BeiGene Ltd. - Segment focus; 12.9 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.10 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.11 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 12.12 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.13 Innovent Biologics Inc.; Innovent Biologics Inc. - Overview; Innovent Biologics Inc. - Product / Service; Innovent Biologics Inc. - Key offerings; 12.14 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.15 Ono Pharmaceutical Co. Ltd.; Ono Pharmaceutical Co. Ltd. - Overview; Ono Pharmaceutical Co. Ltd. - Product / Service; Ono Pharmaceutical Co. Ltd. - Key offerings; 12.16 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.17 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Non-Small Cell Lung Cancer Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Type - Market share 2023-2028 (%); Exhibits33: Data Table on Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Type; Exhibits35: Data Table on Comparison by Type; Exhibits36: Chart on Adenocarcinoma - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Adenocarcinoma - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Adenocarcinoma - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Adenocarcinoma - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Squamous cell carcinoma - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Squamous cell carcinoma - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Squamous cell carcinoma - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Squamous cell carcinoma - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Large cell carcinoma - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Large cell carcinoma - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Large cell carcinoma - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Large cell carcinoma - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Type ($ million); Exhibits49: Data Table on Market opportunity by Type ($ million); Exhibits50: Chart on Product - Market share 2023-2028 (%); Exhibits51: Data Table on Product - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Product; Exhibits53: Data Table on Comparison by Product; Exhibits54: Chart on Biologics - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Biologics - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Biologics - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Biologics - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Small molecule targeted therapy - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Small molecule targeted therapy - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Small molecule targeted therapy - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Small molecule targeted therapy - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Product ($ million); Exhibits67: Data Table on Market opportunity by Product ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: AbbVie Inc. - Overview; Exhibits118: AbbVie Inc. - Product / Service; Exhibits119: AbbVie Inc. - Key news; Exhibits120: AbbVie Inc. - Key offerings; Exhibits121: Amgen Inc. - Overview; Exhibits122: Amgen Inc. - Product / Service; Exhibits123: Amgen Inc. - Key news; Exhibits124: Amgen Inc. - Key offerings; Exhibits125: Astellas Pharma Inc. - Overview; Exhibits126: Astellas Pharma Inc. - Product / Service; Exhibits127: Astellas Pharma Inc. - Key news; Exhibits128: Astellas Pharma Inc. - Key offerings; Exhibits129: AstraZeneca Plc - Overview; Exhibits130: AstraZeneca Plc - Product / Service; Exhibits131: AstraZeneca Plc - Key news; Exhibits132: AstraZeneca Plc - Key offerings; Exhibits133: Bayer AG - Overview; Exhibits134: Bayer AG - Business segments; Exhibits135: Bayer AG - Key news; Exhibits136: Bayer AG - Key offerings; Exhibits137: Bayer AG - Segment focus; Exhibits138: BeiGene Ltd. - Overview; Exhibits139: BeiGene Ltd. - Business segments; Exhibits140: BeiGene Ltd. - Key offerings; Exhibits141: BeiGene Ltd. - Segment focus; Exhibits142: Boehringer Ingelheim International GmbH - Overview; Exhibits143: Boehringer Ingelheim International GmbH - Product / Service; Exhibits144: Boehringer Ingelheim International GmbH - Key news; Exhibits145: Boehringer Ingelheim International GmbH - Key offerings; Exhibits146: Bristol Myers Squibb Co. - Overview; Exhibits147: Bristol Myers Squibb Co. - Product / Service; Exhibits148: Bristol Myers Squibb Co. - Key news; Exhibits149: Bristol Myers Squibb Co. - Key offerings; Exhibits150: Eli Lilly and Co. - Overview; Exhibits151: Eli Lilly and Co. - Product / Service; Exhibits152: Eli Lilly and Co. - Key news; Exhibits153: Eli Lilly and Co. - Key offerings; Exhibits154: F. Hoffmann La Roche Ltd. - Overview; Exhibits155: F. Hoffmann La Roche Ltd. - Business segments; Exhibits156: F. Hoffmann La Roche Ltd. - Key news; Exhibits157: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits158: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits159: Innovent Biologics Inc. - Overview; Exhibits160: Innovent Biologics Inc. - Product / Service; Exhibits161: Innovent Biologics Inc. - Key offerings; Exhibits162: Merck KGaA - Overview; Exhibits163: Merck KGaA - Business segments; Exhibits164: Merck KGaA - Key news; Exhibits165: Merck KGaA - Key offerings; Exhibits166: Merck KGaA - Segment focus; Exhibits167: Ono Pharmaceutical Co. Ltd. - Overview; Exhibits168: Ono Pharmaceutical Co. Ltd. - Product / Service; Exhibits169: Ono Pharmaceutical Co. Ltd. - Key offerings; Exhibits170: Pfizer Inc. - Overview; Exhibits171: Pfizer Inc. - Product / Service; Exhibits172: Pfizer Inc. - Key news; Exhibits173: Pfizer Inc. - Key offerings; Exhibits174: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits175: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits176: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits177: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits178: Inclusions checklist; Exhibits179: Exclusions checklist; Exhibits180: Currency conversion rates for US$; Exhibits181: Research methodology; Exhibits182: Information sources; Exhibits183: Data validation; Exhibits184: Validation techniques employed for market sizing; Exhibits185: Data synthesis; Exhibits186: 360 degree market analysis; Exhibits187: List of abbreviations